85 related articles for article (PubMed ID: 1217497)
1. Potential hypolipidemic agents. XII. Synthesis and plasma lipid-lowering properties of some 3-pyridylmethyl ethers.
Bondesson G; Hedbom C; Magnusson O; Stjernström NE
Acta Pharm Suec; 1975; 12(5-6):445-54. PubMed ID: 1217497
[No Abstract] [Full Text] [Related]
2. Potential hypolipidemic agents. XIII. Synthesis and plasma lipid-lowering properties of some acetals derived from 3-pyridylmethanol or nicotinaldehyde.
Bondesson G; Hedbom C; Magnusson O; Stjernström NE
Acta Pharm Suec; 1976; 13(1):1-8. PubMed ID: 1258658
[No Abstract] [Full Text] [Related]
3. Potential hypolipidemic agents. X. Plasma lipid-lowering properties of some aliphatic aminoalcohols.
Bondesson G; Hedbom C; Magnusson O; Stjernström NE
Acta Pharm Suec; 1974 Nov; 11(5):417-26. PubMed ID: 4440500
[No Abstract] [Full Text] [Related]
4. Potential hypolipidemic agents. XVI. Synthesis and plasma lipid-lowering properties of alpha-substituted ethyl 4-dibenzofuranyloxyacetates and ethyl 4-chlorophenoxyacetates. A comparative study.
Högberg T; Bondesson G; Misiorny A; Stjernström NE
Acta Pharm Suec; 1977; 14(2):137-48. PubMed ID: 906831
[No Abstract] [Full Text] [Related]
5. Potential hypolipidemic agents. XI. Synthesis, plasma lipid-lowering properties and bioavailability of some esters of 2-(4-dibenzofuranoloxy)-2-methylpropionic acid.
Bondesson G; Högberg T; Magnusson O; Stjernström NE
Acta Pharm Suec; 1975; 12(4):361-74. PubMed ID: 1199735
[No Abstract] [Full Text] [Related]
6. Synthesis and hypolipidemic activity of some new esters of glycerol and 2-O-methyl-glycerol with nicotinic and 5-fluoro-nicotinic acids.
Dall'Asta L; Comini A; Borella F; Berti MA; Coppi G
Boll Chim Farm; 1989 Mar; 128(3):106-10. PubMed ID: 2775523
[TBL] [Abstract][Full Text] [Related]
7. Potential hypolipidemic agents. XIV. Synthesis and plasma lipid-lowering properties of substituted biphenyls, diphenyl ethers and benzofurans related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate.
Bondesson G; Högberg T; Misiorny A; Stjernström NE
Acta Pharm Suec; 1976; 13(2):97-106. PubMed ID: 937013
[No Abstract] [Full Text] [Related]
8. [Comparative clinico-pharmacological studies on the lipid lowering effect of EMO 100 and clofibrate].
Leopold G; Simane Z; Stoll KD; Breuer J
Med Welt; 1975 Aug; 6(35):1542-4. PubMed ID: 1177741
[No Abstract] [Full Text] [Related]
9. Pantetheine and pantethine esters with hypolipidemic nicotinic acid derivatives.
Picciòla G; Calvi E; Ravenna F; Gentili P; Manzardo S; Riva M
Arzneimittelforschung; 1985; 35(12):1768-71. PubMed ID: 4096728
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis and hypotriglyceridemic effect of various 2-phenylthis-3-pyridinesulfonamides].
Delarge J; Ghys A
Farmaco Sci; 1983 Jan; 38(1):9-14. PubMed ID: 6825834
[No Abstract] [Full Text] [Related]
11. 2-Substituted-3-pyridinolethers as hypolipidemic and platelet aggregation inhibiting agents.
Desideri N; Manna F; Stein ML; Vairo G; Del Gaudio F; Gentile B; Marmo E
Farmaco Sci; 1985 Sep; 40(9):630-44. PubMed ID: 3841074
[TBL] [Abstract][Full Text] [Related]
12. Hypolipidemic activity of 1-acyl- and 1,2-diacyl-3,5-pyrazolidinediones.
Izydore RA; Bernal-Ramirez JA; Okwisa WA; Yarborough LV; Wong OT; Hall IH
Pharmazie; 1993 Feb; 48(2):111-7. PubMed ID: 8475157
[TBL] [Abstract][Full Text] [Related]
13. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
Högberg T; Bondesson G; Stjernström NE
Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
[No Abstract] [Full Text] [Related]
14. Potential hypolipidemic agents. XV Synthesis and plasma lipid-lowering properties of derivatives of 2-phenoxy-2-methylpropionic acid.
Högberg T; Bondesson G; Misiorny A; Stjernström NE
Acta Pharm Suec; 1976; 13(5-6):427-38. PubMed ID: 1020658
[No Abstract] [Full Text] [Related]
15. Potential hypolipidemic agents. 3. Heterocyclic compounds affecting free fatty acid mobilization in vivo.
Carlson LA; Hedbom C; Helgstrand E; Sjöberg B; Stjernström NE
Acta Pharm Suec; 1972 Sep; 9(4):289-304. PubMed ID: 4655344
[No Abstract] [Full Text] [Related]
16. Lowering of serum lipid levels by "masked" nicotinic acid derivatives.
Bailey DM; Wood D; Johnson RE; McAuliff JP; Bradford JC; Arnold A
J Med Chem; 1972 Apr; 15(4):344-8. PubMed ID: 5019547
[No Abstract] [Full Text] [Related]
17. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
Maroto ML; Priego JG; Piña M; Catalán RE
Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
[No Abstract] [Full Text] [Related]
18. Studies on antihyperlipidemic agents. I. Synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives.
Kawamatsu Y; Saraie T; Imamiya E; Nishikawa K; Hamuro Y
Arzneimittelforschung; 1980; 30(3):454-9. PubMed ID: 7387754
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and hypolipidemic evaluation of beta-alkylaminopropiophenone and beta-alkylaminopropio-2'-naphthone derivatives in rodents.
Huang Y; Hall IH
Pharmazie; 1996 Apr; 51(4):199-206. PubMed ID: 8628737
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and hypolipidemic activity of novel 2-(m-tolyloxy) isobutyric acid derivatives.
Idrees GA; Abuo-Rahma Gel-D; Aly OM; Radwan MF
Eur J Med Chem; 2009 Jun; 44(6):2679-84. PubMed ID: 19121550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
